Renol Polychem Limited Details Compliance Status for Quarter Ended June 30, 2026
Renol Polychem Limited has certified its compliance mechanisms regarding Structured Digital Database (SDD) controls and Unpublished Price Sensitive Information (UPSI) for the quarter ended June 30, 2026. The certificate confirms that the company maintains a Structured Digital Database to manage insider trading requirements.The reporting details specify several key aspects of the company's internal systems designed to track and manage UPSI. These include maintaining an SDD in place, ensuring controlled access to the database, and recording all UPSI disseminated during the previous quarter into this system. The system is designed to capture the nature of the UPSI along with its corresponding date and time.
Management confirmed that the database has been maintained internally, complete with an audit trail. Furthermore, the database is noted as being non-tamperable and is equipped with the capability to maintain records for a period of 8 years.
During the quarter ended June 30, 2026, Renol Polychem Limited was required to capture one event.
The compliance report also noted that noncompliance(s) were observed during the previous quarter. The certificate states that remedial actions have been taken concerning these observations and provides timelines for the corrective measures.
RNPL Stock Price Movement
Shares of Renol Polychem Limited shed 0.71% on Friday, concluding trading at ₹83.9.The stock saw a total traded volume of 9,600 shares during the session.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.